BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Scaling
Trending higher, above historical average, structural decline.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-2.54M
↑ 97% above average
Average (9y)
$-94.63M
Historical baseline
Range
High:$-2.54M
Low:$-177.72M
CAGR
-26.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-2.54M | +97.5% |
| 2023 | $-103.71M | +30.1% |
| 2022 | $-148.44M | +16.5% |
| 2021 | $-177.72M | -1.7% |
| 2020 | $-174.76M | -75.7% |
| 2019 | $-99.45M | -5.6% |
| 2018 | $-94.22M | -64.1% |
| 2017 | $-57.41M | -18.1% |
| 2016 | $-48.61M | -23.2% |
| 2015 | $-39.44M | - |